Not your typical stock investor.
Expressing the minds of the everyday investor.
Everything said is a personal opinion, not a financial advisor. Please DYODD!
We are thrilled to see our revenues growing consistently. Our margins are robust, and we are increasingly profitable.
We fully expect to show continued profits going forward while building on our momentum.
Read more here: https://t.co/dNUI0mV53T
$AYUR
#potstocks#cannabis
Ayurcann Holdings $AYUR in the cannabis sector is trading at a fraction of the multiple of it's competitors and yet has
No Debt
Positive EBITDA
Major growth potential.
IMO few investors know this 💎
Time to take a deeper look!
https://t.co/zpFZuTULJX
#smallcap#Trader#investing
#News: After being named one of the world's leading companies in exosome research, we announce filling our unique Cannabinoids loaded exosome delivery platform together with @TelAvivUni. And the best is yet to come, so stay tuned! $INNO $IP4 $INNPF
https://t.co/3hltnlfyAY
Product quality, experience, and value are foremost in our offerings.
Consumers are making decisions based on the value in the vape and bottled oil products and Ayurcann and its brands are excelling in fulfilling those needs.
$AYUR
https://t.co/2gk9R8IWg2
@ayurcann This company is the #GOAT . Consistently strong PR’s and perhaps the modern impressive financials for a startup cannabis company I’ve ever seen
@jw0085@radovandr@TheValensCo It look's like they've stepped away from tolling and extraction services and are moving towards bringing brands to the market instead. Way to competitive, no price differentiation from their products. Maybe its a little bit better here or there but nothing crazy to catch my eye
@jw0085@radovandr@TheValensCo They changed their entire business model because what they were doing wasn't working. I look at everything from a non-biased standard.